title: [Current treatment of follicular lymphoma].
abstract: After diffuse large B-cell lymphoma, follicular lymphoma is the most frequent non-Hodgkin's lymphoma. It remains incurable, except for localized diseases. Advanced disease has to be treated only in the presence of clinical and/or biology aggressiveness. These patients should be treated by rituximab (Mab-Thera) associated to polychemotherapy comprising cyclophosphamide, vincristine and prednisone. After this therapy, the benefit of rituximab in maintenance has to be confirmed. Autologous stem cell transplantation is now reserved for young patients in first relapse. Allogenic stem cell transplantation is also an interesting option. The other therapeutic options comprise radio-immunotherapy with 90Y ibritumomab tiuxetan (Zevalin) and bortezomib (Velcade).
authors.affiliation: Service d'hématologie clinique, CHU Sart-Tilman, 4000 Liège, Belgique.
authors.forename: C
authors.initials: C
authors.lastname: Bonnet
authors.forename: Y
authors.initials: Y
authors.lastname: Beguin
authors.forename: B
authors.initials: B
authors.lastname: Deprijck
authors.forename: L
authors.initials: L
authors.lastname: de Leval
authors.forename: G
authors.initials: G
authors.lastname: Fillet
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D011719:Pyrazines / Q000008:administration & dosage; D016499:Radioimmunotherapy; D018714:Radiotherapy, Adjuvant; D012307:Risk Factors; D000069283:Rituximab; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001897:Boronic Acids; D011719:Pyrazines; D000069283:Rituximab; C422802:ibritumomab tiuxetan; D014750:Vincristine; D000069286:Bortezomib; D003520:Cyclophosphamide; D011241:Prednisone